Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)

2013166 citationsReview

Authors

Good health and well-being

Published in: Drug Safety

Volume 36, Issue 5, pp. 295-316

Field-Weighted Citation Impact: 10.12